eplivanserin (SR46349)

DRUG5 trials

Sponsors

Sanofi

Conditions

Chronic PainFibromyalgiaInsomniaSleepSleep Initiation and Maintenance Disorders

Phase 1

Single Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluation of Eplivanserin in Children With Insomnia

CompletedNCT00913614

SanofiSleep Initiation and Maintenance Disorders

Start: 2009-06-30End: 2009-12-31Updated: 2010-11-30

Phase 2

Efficacy and Safety of SR46349B in Patients With Sleep Disorders in Fibromyalgia

CompletedNCT00313885

SanofiChronic Pain, Fibromyalgia, Sleep

Start: 2004-04-30End: 2005-06-30Updated: 2010-11-30

Phase 3

Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 Year

CompletedNCT00253903

SanofiInsomnia, Sleep Initiation and Maintenance Disorders

Start: 2005-11-30End: 2008-09-30Updated: 2010-11-30

Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia

CompletedNCT00308503

SanofiInsomnia, Sleep Initiation and Maintenance Disorders

Start: 2006-02-28End: 2007-08-31Updated: 2010-11-30

Comparison of Eplivanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties

CompletedNCT00679900

SanofiSleep Initiation and Maintenance Disorders

Start: 2008-04-30End: 2009-03-31Updated: 2010-11-30